Thoracic radiation therapy during coronavirus disease 2019: Provisional guidelines from a comprehensive cancer center within a pandemic epicenter Editorial

   


Authors: Wu, A. J.; Rimner, A.; Shepherd, A. F.; Gelblum, D. Y.; Shaverdian, N.; Yorke, E.; Simone, C. B. 2nd; Gomez, D. R.
Title: Thoracic radiation therapy during coronavirus disease 2019: Provisional guidelines from a comprehensive cancer center within a pandemic epicenter
Abstract: Coronavirus disease 2019 is an unprecedented pandemic with significant and evolving impact on the practice of radiation oncology. Radiation oncology departments must anticipate and account for coronavirus disease 2019 exposure risk for both patients and staff. The potential for severe radiation therapy resource constraints, particularly due to staff illness, must also be considered. Here we present provisional guidelines for thoracic radiation therapy adopted at our facility, a high-volume cancer center located in a United States pandemic epicenter. Generally, these guidelines reflect the principle that where evidence-supported hypofractionated schedules with comparable efficacy and toxicity exist, the shortest such schedules should be employed. In addition, we discuss potential adaptations in the prioritization and timing of radiation therapy for thoracic malignancies under these circumstances. © 2020 The Authors
Keywords: advanced cancer; united states; cancer radiotherapy; postoperative care; cancer staging; cancer palliative therapy; practice guideline; skull irradiation; cancer center; early cancer; thorax radiography; small cell lung cancer; non small cell lung cancer; pandemic; hypofractionated radiotherapy; human; priority journal; article; high volume hospital; coronavirus disease 2019
Journal Title: Advances in Radiation Oncology
Volume: 5
Issue: 4
ISSN: 2452-1094
Publisher: Elsevier Inc.  
Date Published: 2020-07-01
Start Page: 603
End Page: 607
Language: English
DOI: 10.1016/j.adro.2020.04.008
PROVIDER: scopus
PMCID: PMC7169880
PUBMED: 32318643
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084399056&doi=10.1016%2fj.adro.2020.04.008&partnerID=40&md5=8a56604a34b82ca3b5241558a8c83298
Notes: Article -- Export Date: 1 September 2020 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Daphna Y Gelblum
    227 Gelblum
  2. Daniel R Gomez
    237 Gomez
  3. Andreas Rimner
    524 Rimner
  4. Abraham Jing-Ching Wu
    401 Wu
  5. Ellen D Yorke
    450 Yorke
  6. Annemarie Fernandes Shepherd
    103 Shepherd
  7. Narek Shaverdian
    98 Shaverdian
  8. Charles Brian Simone
    190 Simone
Related MSK Work